Navigation Links
Healthcare Startup Offers Remote Cardiac Monitoring During COVID-19 Pandemic
Date:5/11/2020

Octagos Health, a Houston-based company, recently launched a next generation remote monitoring software platform for patients with implanted cardiac devices. The Octagos software allows healthcare professionals access to cardiac patients’ pacemaker, defibrillator or loop recorder data using one portal. The software greatly simplifies the management of remote transmissions and at the same time provides real-time patient insights and analytics in a secure, cloud-based platform. The Octagos software is also able to further improve efficiency with capabilities such as integrating data from over 70 electronic health record (EHR) companies. By streamlining this information, Octagos makes it easy for providers to monitor all of their patients’ device data and reduce the possible liability of missing critical transmissions.

While Octagos boosts efficiency and saves time on administrative tasks, the software is especially helpful in the age of COVID-19. Cardiac patients are more vulnerable to the coronavirus than the general population, and healthcare providers are facing overwhelming demand while coping with limited resources. Remote software gives providers the ability to provide high quality care for patients without physical contact. This helps to keep at-risk patients safe while also allowing doctors to manage their time and resources more efficiently.

"When the COVID crisis hit I was worried about how I was going to take care of my patients,” said Dr. Shanti Bansal, a Houston physician who also serves as the Director of Medical Affairs for Octagos. “Through the use of the service and software of Octagos, I was able to quickly and easily see all my patients' device information without the worry of missing anything. I was able not only to talk to them about how they were doing, but also to make decisions for their care with relevant data.”

While home monitoring is effective, many of these remote tools are still under-used. For Eric Olsen, SVP of Commercial Operations at Octagos, there was a clear opportunity to create new software supported by strong service to address these issues. “It is apparent that remote monitoring continues to be underutilized despite the abundance of data supporting its effectiveness, to include a Class IA recommendation by the Heart Rhythm Society. Our software and service model remove the barriers patients and physicians face on a daily basis that lead to this under utilization,” says Olsen.

“We provide the necessary support, such as live representatives and a robust software platform, to ensure patients are consistently transmitting their device data from home. We also reduce the cost of care by providing physician practices with the necessary infrastructure that would be cost prohibitive to implement at the practice level. Our software and service model also greatly improve the consistency and predictability of appropriate billing, which is often very hard for practices to manage.”

About Octagos Health: Octagos Health creates cutting-edge software for remote cardiac monitoring backed by a team of very experienced cardiac device experts. The Octagos platform allows healthcare professionals to monitor all of their implanted cardiac device patients using a single platform, streamlining the monitoring process. The Octagos team combines powerful digital monitoring with the personal touch that patients expect from their medical professionals. The result is a revolutionized monitoring process that patients and providers can trust.

Providers can learn more about Octagos Health and schedule a software demo by visiting octagoshealth.com. For additional information, please contact Octagos directly by emailing info@octagoshealth.com or by calling 281-769-8733.

Connect with us https://www.linkedin.com/company/octagoshealth.

Read the full story at https://www.prweb.com/releases/healthcare_startup_offers_remote_cardiac_monitoring_during_covid_19_pandemic/prweb17111550.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. ILC Dover Reacts to Rising Demand for PPE During the COVID-19 Crisis, Rapidly Launches a New Healthcare Respirator Innovation
2. Quick Healthcare Logistics Sponsors World Cord Blood Day 2019
3. Biopharma Leaders Convene to Discuss Topics in Biotech, Healthcare and Innovation at LeadingBiotech’s Inaugural South CEO Conference
4. Top 50 Healthcare Technology CEOs of 2019
5. Intalere Teams with Ambry Genetics to Offer Healthcare Providers Advanced Genetic Testing for Cancer Risk Assessment
6. LaunchBio's Invest in Cures Forum February 13 Offers Insights, Connections into Impact Investing in Healthcare
7. Concerto HealthAI to Present at J.P. Morgan’s 37th Annual Healthcare Conference
8. uBiome to Host Second Annual Microbiome Conference at JP Morgan 37th Annual Healthcare Conference
9. Greenberg Traurig Hosts Boston Healthcare Drinks and Discussion on China Biopharma Industry
10. Persivia Selected by Prime Healthcare to Provide Bundled Payment Solution to 34 Hospitals for BPCI Advanced Support
11. Slone Partners, Where People Are Our Science®, Announces Insights: Scientific Healthcare Investing 2018 Panel Event With Leaders In The Investment Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2020)... ... 18, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology ... and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application ... COVID-19. Approval of this IND allows Sentien to initiate a Phase 1/2 study ...
(Date:8/12/2020)... ... August 11, 2020 , ... Both Roche, ... have entered into license agreements with Housey Pharma’s HMI subsidiary to gain access ... J&J have annual Research and Development spending in excess of US $10 billion. ...
(Date:8/5/2020)... ... ... Regenative Labs has received approval from the Centers for Medicare & Medicaid ... Wharton’s jelly allografts to be assigned a Q code and be approved for application ... jelly allograft product to be recognized as a 361 HCT/P by CMS regulated under ...
Breaking Biology News(10 mins):
(Date:8/7/2020)... ... August 06, 2020 , ... VGXI, a highly regarded CDMO ... the purchase of greenfield for a new, expanded manufacturing facility. The site is ... in the initial acquisition, with an option to purchase an additional 21 acres ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... Anomet Products ... three different materials for use with CRM, neurostimulation, vascular, and related devices. , ... meet specific design requirements, performance, and cost criteria; especially where solid wire is ...
(Date:7/31/2020)... ... July 29, 2020 , ... The SDX® Respiratory Gating ... countries, has reached its 20th anniversary of worldwide use. Introduced in the US ... universities including University of Pennsylvania, University of Michigan, University of Maryland, University of ...
Breaking Biology Technology: